ADTX Insider Trading

Insider Ownership Percentage: 2.08%
Insider Buying (Last 12 Months): $20,000.00
Insider Selling (Last 12 Months): $0.00

Aditxt Insider Trading History Chart

This chart shows the insider buying and selling history at Aditxt by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aditxt Share Price & Price History

Current Price: $1.64
Price Change: Price Decrease of -0.03 (-1.80%)
As of 12/9/2022 06:20 PM ET

This chart shows the closing price history over time for ADTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Aditxt Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/19/2022Amro A AlbannaCEOBuy1$20,000.00$20,000.001View SEC Filing Icon  
6/1/2021Shahrokh ShabahangInsiderBuy490$2.93$1,435.70View SEC Filing Icon  
5/26/2021Thomas J. FarleyInsiderBuy2,500$2.68$6,700.002,500View SEC Filing Icon  
5/25/2021Corinne PankovcinCFOBuy4,220$2.56$10,803.20114,220View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Aditxt (NASDAQ:ADTX)

4.81% of Aditxt stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ADTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aditxt Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/8/2022Bank of New York Mellon Corp34,968$0.12M0.0%N/A2.989%Search for SEC Filing on Google Icon
11/16/2022Jane Street Group LLC19,739$67K0.0%-71.0%1.687%Search for SEC Filing on Google Icon
11/15/2022State Street Corp37,898$0.13M0.0%-55.4%3.250%Search for SEC Filing on Google Icon
11/15/2022Bank of New York Mellon Corp34,968$0.12M0.0%N/A2.989%Search for SEC Filing on Google Icon
11/10/2022UBS Group AG12,001$41K0.0%-60.3%1.026%Search for SEC Filing on Google Icon
8/13/2022Virtu Financial LLC495,665$71K0.0%N/A0.895%Search for SEC Filing on Google Icon
4/21/2022Inspire Advisors LLC227,113$0.10M0.0%+15.5%0.508%Search for SEC Filing on Google Icon
2/3/2022Inspire Investing LLC196,592$0.11M0.0%N/A1.338%Search for SEC Filing on Google Icon
11/16/2021CVI Holdings LLC588,942$1M0.1%N/A4.010%Search for SEC Filing on Google Icon
11/9/2021Inspire Advisors LLC15,065$25K0.0%N/A0.103%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC92,015$0.24M0.0%+12.5%0.626%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.197,093$0.51M0.0%+16.6%1.342%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC69,265$0.18M0.0%+322.4%0.000%Search for SEC Filing on Google Icon
5/14/2021XTX Topco Ltd10,081$26K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp19,163$49K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC81,786$0.21M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC16,398$34K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/12/2021Credit Suisse AG51,912$0.11M0.0%N/A0.000%Search for SEC Filing on Google Icon
10/20/2020Wedbush Securities Inc.61,832$0.12M0.0%N/A0.000%Search for SEC Filing on Google Icon
10/7/2020Powell Investment Advisors LLC38,500$75K0.1%N/A0.000%Search for SEC Filing on Google Icon
8/12/2020Hudson Bay Capital Management LP108,961$0.55M0.0%N/A0.000%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aditxt logo
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
Read More on Aditxt

Today's Range

Now: $1.64
Low: $1.61
High: $1.67

50 Day Range

MA: $2.40
Low: $1.58
High: $4.02

52 Week Range

Now: $1.64
Low: $1.57
High: $41.15

Volume

42,934 shs

Average Volume

798,454 shs

Market Capitalization

$1.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7

Who are the company insiders with the largest holdings of Aditxt?

Aditxt's top insider shareholders include:
  1. Corinne Pankovcin (CFO)
  2. Thomas J Farley (Insider)
  3. Amro A Albanna (CEO)
  4. Shahrokh Shabahang (Insider)
Learn More about top insider investors at Aditxt.

Who are the major institutional investors of Aditxt?

Aditxt's top institutional investors include:
  1. State Street Corp — 3.25%
  2. Bank of New York Mellon Corp — 2.99%
  3. Bank of New York Mellon Corp — 2.99%
  4. Jane Street Group LLC — 1.69%
  5. UBS Group AG — 1.03%
  6. Citadel Advisors LLC — 0.00%
Learn More about top institutional investors of Aditxt stock.

Which institutional investors are selling Aditxt stock?

During the last quarter, ADTX stock was sold by these institutional investors:
  1. Citadel Advisors LLC
  2. Jane Street Group LLC
  3. State Street Corp
  4. UBS Group AG

Which institutional investors are buying Aditxt stock?

Within the previous quarter, ADTX stock was acquired by institutional investors including:
  1. Bank of New York Mellon Corp
  2. Bank of New York Mellon Corp
Within the previous year, these company insiders have bought Aditxt stock:
  1. Corinne Pankovcin (CFO)
  2. Thomas J Farley (Insider)
  3. Amro A Albanna (CEO)
  4. Shahrokh Shabahang (Insider)
Learn More investors buying Aditxt stock.